Abstract
While there are over 100 distinct mutations in the rhodopsin gene that are found in patients with the degenerative disease autosomal dominant retinitis pigmentosa (ADRP), there are only four known mutations in the rhodopsin gene found in patients with the dysfunction congenital stationary night blindness (CSNB). CSNB patients have a much less severe phenotype than those with ADRP; the patients only lose rod function which affects their vision under dim light conditions, whereas their cone function remains relatively unchanged. The known rhodopsin CSNB mutations are found clustered around the site of retinal attachment. Two of the mutations encode replacements of neutral amino acids with negatively charged ones (A292E and G90D), and the remaining two are neutral amino acid replacements (T94I and A295V). All four of these mutations have been shown to constitutively activate the apoprotein in vitro. The mechanisms by which these mutations lead to night blindness are still not known with certainty, and remain the subject of some controversy. The dominant nature of these genetic defects, as well as the relative normalcy of vision in individuals with half the complement of wild type rhodopsin, suggest that it is an active property of the mutant opsin proteins that leads to defective rod vision rather than a loss of some needed function. Herein, we review the known biochemical and electrophysiological data for the four known rhodopsin mutations found in patients with CSNB.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
al-Jandal N, Farrar GJ, Kiang A-S et al (1999) A novel mutation within the rhodopsin gene (Thr-94-Ile) causing autosomal dominant congenital stationary night blindness. Hum Mutat 13:75–81
Barlow HB (1988) The thermal limit to seeing. Nature 334:296–297
Baylor DA, Matthews G, Yau KW (1980) Two components of electrical dark noise in road retinal rod outer segments. J Physiol 309:591–621
Baylor DA, Nunn BJ, Schnapf JL (1984) The photocurrent, noise and spectral sensitivity of rods of the monkey Macaca fascicularis. J Physiol (Lond) 357:575–607
Cornwall MC, Fain GL (1994) Bleaching pigment activates transducin in isolated rods of the salamander retina. J Physiol (Lond) 480:261–279
Dizhoor A, Woodruff M, Olshevskaya E et al (2008) Night blindness and the mechanism of constitutive signaling of mutant G90D rhodopsin. J Neurosci 28:11662–11672
Dowling JE (1960) Chemistry of visual adaptation in the rat. Nature 188:114–118
Dryja TP, Berson EL, Rao VR et al (1993) Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness. Nat Genet 4:280–283
Gal A, Orth U, Baehr W et al (1994) Heterozygous missense mutation in the rod cGMP phosphodiesterase beta-subunit gene in autosomal dominant stationary night blindness. Nat Genet 7:551
Gross AK, Rao VR, Oprian DD (2003) Characterization of rhodopsin congenital night blindness mutant T94I. Biochemistry 42:2009–2015
Gross AK, Xie G, Oprian DD (2003) Slow binding of retinal to rhodopsin mutants G90D and T94D. Biochemistry 42:2002–2008
Jin S, Cornwall MC, Oprian DD (2003) Opsin activation as a cause of congenital night blindness. Nat Neurosci 6:731–735
Keen TJ, Inglehearn CF, Lester DH et al (1991) Autosomal dominant retinitis pigmentosa: four new mutations in rhodopsin, one of the in the retinal attachment site. Genomics 11:199–205
Krispel CM, Chen D, Melling N et al (2006) RGS expression rate-limits recovery of rod photoresponses. Neuron 51:409–416
Krispel CM, Chen CK, Simon MI et al (2003) Novel form of adaptation in mouse retinal rods speeds recovery of phototransduction. J Gen Physiol 122:703–712
Lem J, Krasnoperova NV, Calvert PD, et al (1999) Morphological, physiological and biochemical changes in rhodopsin knockout mice. Proc Natl Acad Sci USA 96:736–741
Melia TJ, Cowan CW, Angelson JK et al (1997) A comparison of the efficiency of G protein activation by ligand-free and light-activated forms of rhodopsin. Biophys J 73:3182–3191
Nakanishi K, Balogh-Nair V, Arnaboldi M et al (1980) An external point-charge model for bacteriorhodopsin to account for its purple color. J Am Chem Soc 102:7945–7947
Nathans J (1990) Determinants of visual pigment absorbance: identification of the retinylidene Schiff’s base counterion in bovine rhodopsin. Biochemistry 29:9746–9752
Ng PC, Henikoff S (2001) Predicting deleterious amino acid substitutions. Genome Res 11:863–874
Rao V, Cohen GB, Oprian DD (1994) Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature 367:639–642
Rieke F, Baylor DA (1996) Molecular origin of continuous dark noise in rod photoreceptors. Biophys J 71:2553–2572
Robinson PR, Cohen GB, Zhukovsky EA et al (1992) Constitutively active mutants of rhodopsin. Neuron 9:719–725
Sakmar TP, Franke RR, Khorana HG (1989) Glutamic acid-113 serves as the retinylidene Schiff base counterion in bovine rhodopsin. Proc Natl Acad Sci USA 86:8309–8313
Sieving PA, Fowler ML, Bush RA et al (2001) Constitutive “light” adaptation in rods from G90D rhodopsin: a mechanism for human congenital nightblindness without rod cell loss. J Neurosci 21:5449–5460
Sieving PA, Richards JE, Naarendorp F et al (1995) Dark-light: model for nightblindness from the human rhodopsin Gly-90 –> Asp mutation. Proc Natl Acad Sci 92:880–884
Steinberg G, Ottolenghi M, Sheves M (1993) pKa of the protonated Schiff base of bovine rhodopsin: A study with artificial pigments. Biophys J 64:1499–1502
Sullivan JM, Scott KM, Falls HF et al (1993) A novel rhodopsin mutation at the retinal binding site (LYS 296 MET) in ADRP. Invest Ophthalmol Vis Sci 34:1149
Szabo V, Kreienkamp H-J, Rosenberg T et al (2007) p.Gln200Glu, a putative constitutively active mutant of rod á-transducin (GNAT1) in autosomal dominant congenital stationary night blindness. Hum Mutat 28:741–742
Tam B, Moritz O (2007) Dark rearing rescues P23H rhodopsin-induced retinal degeneration in a transgenic Xenopus laevis model of retinitis pigmentosa: a chromophore-dependent mechanism characterized by production of N-terminally truncated mutant rhodopsin. J Neurosci 27(34):9043–9053
Xie G, Gross AK, Oprian DD (2003) An opsin mutant with increased thermal stability. Biochemistry 42:1995–2001
Zeitz C, Gross AK, Leifert D et al (2008) Identification and functional characterization of a novel rhodopsin mutation associated with autosomal dominant CSNB. Invest Ophthalmol Visc Sci 49:4105–4114
Zhukovsky EA, Robinson PR, Oprian DD (1992) Changing the location of the Schiff base counterion in rhodopsin. Biochemistry 31:10400–10405
Acknowledgments
The authors thank T.G. Wensel and V.E. Wotring for critical comments on this manuscript. Our research is supported by grants from the EyeSight Foundation of Alabama, the Karl Kirchgessner Foundation, and by NIH grant EY019311.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
McAlear, S.D., Kraft, T.W., Gross, A.K. (2010). 1 Rhodopsin Mutations in Congenital Night Blindness. In: Anderson, R., Hollyfield, J., LaVail, M. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 664. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1399-9_30
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1399-9_30
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1398-2
Online ISBN: 978-1-4419-1399-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)